Minimed Group, Inc. is a medical technology company that develops, manufactures, and markets medical equipment for the management of diabetes. The company is headquartered in Northridge, California.
| Revenue (TTM) | $3.10B |
| Gross Profit (TTM) | $1.68B |
| EBITDA | $-16.00M |
| Operating Margin | -10.30% |
| Return on Equity | -9.28% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $12.09 |
| Book Value | $12.33 |
| Price-to-Book | 1.25 |
| Price-to-Sales (TTM) | 1.39 |
| EV/Revenue | 1.454 |
| EV/EBITDA | 96.59 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 15.60% |
| Shares Outstanding | $280.82M |
| Float | $28.00M |
| % Insiders | 90.51% |
| % Institutions | 11.60% |
Volatility is currently expanding